A novel delivery system for continuous desferrioxamine infusion in transfusional iron overload

British Journal of Haematology

Volumn 93, Issue 4, 1996, Pages 835-837

  Araujo, A ^a   Kosaryan, M ^a   Macdowell, A ^c   Wickens, D ^a   Puri, S ^a   Wonke, B ^a   Hoffbrand, A V ^b  

^a WHITTINGTON HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c Baxter Healthcare Ltd   (United Kingdom)

Author keywords

desferrioxamine; iron overload; novel infusors

Indexed keywords

DEFEROXAMINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON OVERLOAD; MALE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SUBCUTANEOUS DRUG ADMINISTRATION; THALASSEMIA;

EID: 0029894858     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1743.x     Document Type: Article

References (4)

1. 1. British Journal of Haematology, 82, 431-436.
2. Araujo, A., Kosaryan, M., MacDowell, A., Wickens, D., Puri, S. & Wonke, B. (1995) A novel delivery system for continuous subcutaneous desferrioxamine infusion in thalassaemia major and sickle cell disease. British Journal of Haematology, 89, (Suppl. 1), 87.
3. Gutteridge, J.M.C. & Halliwell, B. (1989) Iron toxicity and oxygen radicals. Bailliere's Clinical Hematology, 2, 195-256.
4. Singh, S., Hider, R.C. & Porter, J.B. (1990) A direct method of quantification of non-transferrin bound iron. Analytical Biochemistry, 186, 320-323.